157 related articles for article (PubMed ID: 37522557)
21. TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion.
Pokrishevsky E; Grad LI; Cashman NR
Sci Rep; 2016 Mar; 6():22155. PubMed ID: 26926802
[TBL] [Abstract][Full Text] [Related]
22. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
[TBL] [Abstract][Full Text] [Related]
23. Research progress on vesicular trafficking in amyotrophic lateral sclerosis.
Yang C; Zhang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 51(3):380-387. PubMed ID: 36161717
[TBL] [Abstract][Full Text] [Related]
24. Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis.
Goutman SA; Chen KS; Paez-Colasante X; Feldman EL
Handb Clin Neurol; 2018; 148():603-623. PubMed ID: 29478603
[TBL] [Abstract][Full Text] [Related]
25. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord.
Yoshikawa M; Ishikawa C; Li H; Kudo T; Shiba D; Shirakawa M; Muratani M; Takahashi S; Aizawa S; Shiga T
Mol Cell Neurosci; 2022 Jul; 121():103745. PubMed ID: 35660087
[TBL] [Abstract][Full Text] [Related]
26. Could Sirtuin Activities Modify ALS Onset and Progression?
Tang BL
Cell Mol Neurobiol; 2017 Oct; 37(7):1147-1160. PubMed ID: 27942908
[TBL] [Abstract][Full Text] [Related]
27. Characterizing the multiple roles of FGF-2 in SOD1
Kefalakes E; Böselt S; Sarikidi A; Ettcheto M; Bursch F; Naujock M; Stanslowsky N; Schmuck M; Barenys M; Wegner F; Grothe C; Petri S
J Cell Physiol; 2019 May; 234(5):7395-7410. PubMed ID: 30370540
[TBL] [Abstract][Full Text] [Related]
28. CRISPR/Cas9-Mediated Gene Correction to Understand ALS.
Yun Y; Ha Y
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471232
[TBL] [Abstract][Full Text] [Related]
29. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism.
Keller BA; Volkening K; Droppelmann CA; Ang LC; Rademakers R; Strong MJ
Acta Neuropathol; 2012 Nov; 124(5):733-47. PubMed ID: 22941224
[TBL] [Abstract][Full Text] [Related]
30. NEAT1 lncRNA and amyotrophic lateral sclerosis.
Nishimoto Y; Nakagawa S; Okano H
Neurochem Int; 2021 Nov; 150():105175. PubMed ID: 34481908
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.
Wang L; Yi F; Fu L; Yang J; Wang S; Wang Z; Suzuki K; Sun L; Xu X; Yu Y; Qiao J; Belmonte JCI; Yang Z; Yuan Y; Qu J; Liu GH
Protein Cell; 2017 May; 8(5):365-378. PubMed ID: 28401346
[TBL] [Abstract][Full Text] [Related]
32. Axonal transport defects are a common phenotype in Drosophila models of ALS.
Baldwin KR; Godena VK; Hewitt VL; Whitworth AJ
Hum Mol Genet; 2016 Jun; 25(12):2378-2392. PubMed ID: 27056981
[TBL] [Abstract][Full Text] [Related]
33. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
[TBL] [Abstract][Full Text] [Related]
34. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
[TBL] [Abstract][Full Text] [Related]
35. The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS.
Dzhashiashvili Y; Monckton CP; Shah HS; Kunjamma RB; Popko B
Neurobiol Dis; 2019 Jul; 127():527-544. PubMed ID: 30923003
[TBL] [Abstract][Full Text] [Related]
36. The genetics and neuropathology of amyotrophic lateral sclerosis.
Al-Chalabi A; Jones A; Troakes C; King A; Al-Sarraj S; van den Berg LH
Acta Neuropathol; 2012 Sep; 124(3):339-52. PubMed ID: 22903397
[TBL] [Abstract][Full Text] [Related]
37. Misfolded SOD1 inclusions in patients with mutations in
Forsberg K; Graffmo K; Pakkenberg B; Weber M; Nielsen M; Marklund S; Brännström T; Andersen PM
J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):861-869. PubMed ID: 30992335
[TBL] [Abstract][Full Text] [Related]
38. Current developments in gene therapy for amyotrophic lateral sclerosis.
Scarrott JM; Herranz-Martín S; Alrafiah AR; Shaw PJ; Azzouz M
Expert Opin Biol Ther; 2015 Jul; 15(7):935-47. PubMed ID: 25959569
[TBL] [Abstract][Full Text] [Related]
39. Neuro-Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice.
de Munter JPJM; Shafarevich I; Liundup A; Pavlov D; Wolters EC; Gorlova A; Veniaminova E; Umriukhin A; Kalueff A; Svistunov A; Kramer BW; Lesch KP; Strekalova T
CNS Neurosci Ther; 2020 May; 26(5):504-517. PubMed ID: 31867846
[TBL] [Abstract][Full Text] [Related]
40. Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?
Furukawa Y; Tokuda E
Transl Neurodegener; 2020 Aug; 9(1):33. PubMed ID: 32811540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
